Evidence map›Paper›PMID 34205207›Full record

ArticleInternational journal of molecular sciences2021

Sorcin Activates the Brain PMCA and Blocks the Inhibitory Effects of Molecular Markers of Alzheimer's Disease on the Pump Activity.

Maria Berrocal, Lucia Saez, Ana M Mata

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Maria BerrocalDepartamento de Bioquímica y Biología Molecular y Genética, Facultad de Ciencias and Instituto de Biomarcadores de Patologías Moleculares, Universidad de Extremadura, 06006 Badajoz, Spain.
Lucia SaezDepartamento de Bioquímica y Biología Molecular y Genética, Facultad de Ciencias and Instituto de Biomarcadores de Patologías Moleculares, Universidad de Extremadura, 06006 Badajoz, Spain.
Ana M MataDepartamento de Bioquímica y Biología Molecular y Genética, Facultad de Ciencias and Instituto de Biomarcadores de Patologías Moleculares, Universidad de Extremadura, 06006 Badajoz, Spain.ORCID 0000-0002-2887-7854
Universidad de Extremadura · ES

Funding

Ministerio de Economía, Industria y Competitividad, Gobierno de España BFU2017-85723-P
6 · The paper itself

Abstract

Since dysregulation of intracellular calcium (Ca

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesBrainCalciumCalcium-Binding ProteinsCalcium SignalingHumansNeuronsPlasma Membrane Calcium-Transporting ATPasesPresenilin-2Protein BindingProtein Interaction MapsSarcoplasmic Reticulum Calcium-Transporting ATPasestau ProteinsAmyloid beta-PeptidesCalciumCalcium-Binding ProteinsPlasma Membrane Calcium-Transporting ATPasesPresenilin-2PSEN2 protein, humanSarcoplasmic Reticulum Calcium-Transporting ATPasesSRI protein, humantau Proteinsamyloid-β peptidefunctional modulationneurodegenerationplasma membrane Ca2+-ATPase (PMCA)sorcintau

Identifiers

PMID34205207
PMCPMC8200006
OpenAlexW3172764686

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.